We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Synthetech Acquires Peptide Resin Technology From Colorado
News

Synthetech Acquires Peptide Resin Technology From Colorado

Synthetech Acquires Peptide Resin Technology From Colorado
News

Synthetech Acquires Peptide Resin Technology From Colorado

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Synthetech Acquires Peptide Resin Technology From Colorado"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Synthetech, Inc. has acquired the technology assets and customer lists of Colorado Biotechnology Associates, Incorporated (CBA) for a range of cross-linked and functionalized polymeric resins used widely in Solid Phase Peptide Synthesis (SPPS).

Under the arrangement, Dr. Rodger Raubach, CBA's founder and principal owner, will transfer proprietary resin know-how to Synthetech, and serve as a consultant for scale-up, technical support, customer qualification and business development for a period of three years.

The transferred technology includes the procedure to attach the specified terminal amino acid to the resin, a key value-added service to peptide customers.

Synthetech plans to produce and have available for distribution resin batches within the next three months.

Commenting on the transaction, M. "Sreeni" Sreenivasan, Synthetech's President & CEO, said, "SPPS resins represent a product line that is complementary to our established line of peptide building blocks, with a distinct overlap in the customer base."

"Dr. Raubach has developed unique know- how and an enviable reputation in the field of SPPS resins over the past couple of decades. We look forward to working with Dr. Raubach and firmly establishing Synthetech as a world class supplier of high quality resins."

"We believe that with Dr. Raubach's assistance, Synthetech is well positioned to rapidly enter this market."

Dr. Raubach added, "With my desire to retire and wind up CBA, I believe there is no better choice to carry on the work I began in the resin field than Synthetech."

Advertisement